S SKINVIVE BY JUVÉDERM

Serial Number 97006113
Registration 7108819
700

Registration Progress

Application Filed
Sep 1, 2021
Under Examination
May 31, 2022
Approved for Publication
Apr 5, 2022
Published for Opposition
Apr 5, 2022
Registered
Jul 11, 2023

Trademark Image

S SKINVIVE BY JUVÉDERM

Basic Information

Serial Number
97006113
Registration Number
7108819
Filing Date
September 1, 2021
Registration Date
July 11, 2023
Published for Opposition
April 5, 2022
Drawing Code
3

Status Summary

Current Status
Active
Status Code
700
Status Date
Jul 11, 2023
Registration
Registered
Classes
005

Rights Holder

Allergan Holdings France SAS

99
Address
Tour CBX, 1 passerelle des Reflets
Courbevoie 92400
FR

Ownership History

Allergan Holdings France SAS

Original Applicant
99
Courbevoie FR

Allergan Holdings France SAS

Owner at Publication
99
Courbevoie FR

Allergan Holdings France SAS

Original Registrant
99
Courbevoie FR

Legal Representation

Attorney
Matthew O. Brady

USPTO Deadlines

Next Deadline
1295 days remaining
Section 8 Declaration Due (Principal Register) (Based on registration date 20230711)
Due Date
July 11, 2029
Grace Period Ends
January 11, 2030
Additional deadlines exist. Contact your attorney for complete deadline information.

Application History

43 events
Date Code Type Description Documents
Nov 25, 2025 A7OK O AMENDMENT UNDER SECTION 7 - PROCESSED Loading...
Nov 17, 2025 APRE A CASE ASSIGNED TO POST REGISTRATION PARALEGAL Loading...
Sep 3, 2025 ES7R I TEAS SECTION 7 REQUEST RECEIVED Loading...
Jul 11, 2023 NRCC E NOTICE OF REGISTRATION CONFIRMATION EMAILED Loading...
Jul 11, 2023 R.PR A REGISTERED-PRINCIPAL REGISTER Loading...
Jun 8, 2023 SUNA E NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED Loading...
Jun 7, 2023 CNPR P ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED Loading...
Jun 7, 2023 XAEC I EXAMINER'S AMENDMENT ENTERED Loading...
Jun 7, 2023 GNEN O NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED Loading...
Jun 7, 2023 GNEA O EXAMINERS AMENDMENT E-MAILED Loading...
Jun 7, 2023 SNEA W SU-EXAMINER'S AMENDMENT WRITTEN Loading...
Jun 7, 2023 GNRN O NOTIFICATION OF NON-FINAL ACTION E-MAILED Loading...
Jun 7, 2023 GNRT O NON-FINAL ACTION E-MAILED Loading...
Jun 7, 2023 CNRT W SU - NON-FINAL ACTION - WRITTEN Loading...
Jun 1, 2023 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Loading...
May 31, 2023 SUPC I STATEMENT OF USE PROCESSING COMPLETE Loading...
May 31, 2023 EX2G S SOU EXTENSION 2 GRANTED Loading...
May 23, 2023 IUAF S USE AMENDMENT FILED Loading...
May 23, 2023 EXT2 S SOU EXTENSION 2 FILED Loading...
May 30, 2023 AITU A CASE ASSIGNED TO INTENT TO USE PARALEGAL Loading...
May 23, 2023 EEXT I SOU TEAS EXTENSION RECEIVED Loading...
May 23, 2023 EISU I TEAS STATEMENT OF USE RECEIVED Loading...
Apr 10, 2023 TCCA I TEAS CHANGE OF CORRESPONDENCE RECEIVED Loading...
Apr 10, 2023 EWAF I TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS Loading...
Apr 10, 2023 ARAA I ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED Loading...
Apr 10, 2023 REAP I TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED Loading...
Dec 2, 2022 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Loading...
Nov 30, 2022 EX1G S SOU EXTENSION 1 GRANTED Loading...
Nov 30, 2022 EXT1 S SOU EXTENSION 1 FILED Loading...
Nov 30, 2022 EEXT I SOU TEAS EXTENSION RECEIVED Loading...
May 31, 2022 NOAM E NOA E-MAILED - SOU REQUIRED FROM APPLICANT Loading...
Apr 5, 2022 NPUB E OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED Loading...
Apr 5, 2022 PUBO A PUBLISHED FOR OPPOSITION Loading...
Mar 16, 2022 NONP E NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED Loading...
Mar 1, 2022 CNSA P APPROVED FOR PUB - PRINCIPAL REGISTER Loading...
Mar 1, 2022 XAEC I EXAMINER'S AMENDMENT ENTERED Loading...
Mar 1, 2022 GNEN O NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED Loading...
Mar 1, 2022 GNEA F EXAMINERS AMENDMENT E-MAILED Loading...
Mar 1, 2022 CNEA R EXAMINERS AMENDMENT -WRITTEN Loading...
Mar 1, 2022 DOCK D ASSIGNED TO EXAMINER Loading...
Oct 15, 2021 MDSC E NOTICE OF DESIGN SEARCH CODE E-MAILED Loading...
Oct 14, 2021 NWOS I NEW APPLICATION OFFICE SUPPLIED DATA ENTERED Loading...
Sep 4, 2021 NWAP I NEW APPLICATION ENTERED Loading...

Detailed Classifications

Class 005
Pharmaceutical preparations for the treatment of glabellar lines, facial wrinkles, asymmetries and defects and conditions of the human skin; biological dermal implants, namely, visco-supplementation solutions for filling wrinkles
First Use Anywhere: May 15, 2023
First Use in Commerce: May 15, 2023

Additional Information

Design Mark
The mark consists of a stylized teardrop design within which is a stylized letter "S". Centered beneath the design is the word "SKINVIVE" and centered beneath the word "SKINVIVE" are the words "BY JUVÉDERM".
Other
In the statement, line 1, "société à responsabilité limitée (sarl)" is deleted, and "Société par Actions Simplifiée (SAS)"  is inserted.

Classification

International Classes
005